Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
TiumBio Global http://www.tiumbio.com/en/
CONTACT
Lead
TiumBio Co., Ltd.
With
The primary objective of phase 1b is to determine the recommended phase 2 dose of the combination (RP2DC) of TU2218 given with pembrolizumab in advanced solid tumors. The primary objective of phase 2a is to evaluate the efficacy of TU2218 administered in combination with pembrolizumab in selected advanced tumors.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted